Literature DB >> 29717099

Results of a Pulmonologist Survey Regarding Knowledge and Practices With Inhalation Devices for COPD.

Sidney S Braman1, Brian W Carlin2, Nicola A Hanania3, Donald A Mahler4, Jill A Ohar5, Victor Pinto-Plata6, Tina Shah7, David Eubanks8, Rajiv Dhand9.   

Abstract

BACKGROUND: COPD guidelines advise on inhaled medication use, yet no advice is offered on when to use and which type of patient could benefit from a specific delivery device. We investigated pulmonologists' perception of their knowledge and practices with delivery devices for COPD management.
METHODS: An online survey was designed by a steering committee of American Thoracic Society clinicians and scientists and conducted by a national market research firm between January 7 and 29, 2016.
RESULTS: Two hundred and five respondents completed the survey. Nearly 80% of the respondents believed that they were very knowledgeable in COPD management and the use of medications; 68% believed that they were knowledgeable about preventing exacerbations. Ninety-eight percent of the respondents stated that they were at least somewhat knowledgeable about devices. Many respondents (70%) stated that small-volume nebulizers were more effective than dry powder inhalers and pressurized metered-dose inhalers in the management of COPD exacerbations, and 63% believed that these were more effective in severe COPD (modified Medical Research Council dyspnea scale grade 4). Only 54% of the respondents discussed device options with their patients. Physician screening for physical or cognitive impairments that could impact device choices was 53% and 16%, respectively. Seventy percent of the respondents discussed device use, whereas 9% discussed cleaning and storage during a patient's first visit. Few respondents were very knowledgeable in teaching patients how to use devices (43%) and, specifically, how to use (32%) or clean and/or maintain (20%) small-volume nebulizers.
CONCLUSIONS: Most respondents were confident in their knowledge about treating COPD. Fewer respondents were confident about the use and maintenance of inhalation devices, and most respondents desired to learn more about inhalation devices.
Copyright © 2018 by Daedalus Enterprises.

Entities:  

Keywords:  COPD; inhalation therapy; small-volume nebulizers

Mesh:

Year:  2018        PMID: 29717099     DOI: 10.4187/respcare.05717

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  5 in total

1.  The Impact of a Forced Non-Medical Switch of Inhaled Respiratory Medication Among Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Patient Survey on Experience with Switch, Therapy Satisfaction, and Disease Control.

Authors:  Ileen Gilbert; Keiko Wada; Chakkarin Burudpakdee; Chirag Ghai; Laren Tan
Journal:  Patient Prefer Adherence       Date:  2020-08-20       Impact factor: 2.711

2.  The Role of Inhalation Delivery Devices in COPD: Perspectives of Patients and Health Care Providers.

Authors:  Nicola A Hanania; Sidney Braman; Sandra G Adams; Ruth Adewuya; Arzu Ari; JoAnn Brooks; Donald A Mahler; Jill A Ohar; Jay Peters; Shahin Sanjar
Journal:  Chronic Obstr Pulm Dis       Date:  2018-04-01

Review 3.  The environmental impact of inhaled therapy: making informed treatment choices.

Authors:  Ashley Woodcock; Kai M Beeh; Hironori Sagara; Simon Aumônier; Emmanuel Addo-Yobo; Javaid Khan; Jørgen Vestbo; Helen Tope
Journal:  Eur Respir J       Date:  2022-07-21       Impact factor: 33.795

4.  Perceptions and Attitudes of Patients and Their Family Caregivers on Nebulization Therapy for COPD.

Authors:  Harjit Dumra; Arjun Khanna; Sujeet K Madhukar; Meena Lopez; Jaideep Gogtay
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-09-14

5.  In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler®.

Authors:  Jill A Ohar; Andrea Bauer; Sanjay Sharma; Shahin Sanjar
Journal:  Pulm Ther       Date:  2020-08-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.